• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坦桑尼亚一家三级医疗机构中接受经皮冠状动脉介入治疗患者的急性肾损伤患病率及相关因素

Prevalence & Factors Associated With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention at a Tertiary Healthcare Facility in Tanzania.

作者信息

Hooda Faisal, Kassam Nadeem, Somji Samina, Makakala Mandela, Noorani Mariam, Bakshi Fatma, Mvungi Robert

机构信息

Internal Medicine, Aga Khan University Medical College East Africa, Dar es Salaam, TZA.

Pediatric Medicine, Aga Khan University Medical College East Africa, Dar es Salaam, TZA.

出版信息

Cureus. 2023 Mar 16;15(3):e36219. doi: 10.7759/cureus.36219. eCollection 2023 Mar.

DOI:10.7759/cureus.36219
PMID:37065411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10103833/
Abstract

BACKGROUND

Coronary artery disease (CAD) is the leading cause of mortality and morbidity globally. Percutaneous coronary intervention (PCI) is a minimally-invasive lifesaving intervention for these patients; however, acute kidney injury (AKI) is a serious complication of the procedure commonly occurring due to radiocontrast-induced nephropathy.

METHODS

A retrospective cross-sectional analytical study was carried out at the Aga Khan Hospital, Dar es Salaam (AKH,D), Tanzania. A total of 227 adults who underwent a percutaneous coronary intervention from August 2014 to December 2020 were enrolled. The AKI was defined based on an increase in absolute and rise in percentage creatinine using the Acute Kidney Injury Network (AKIN), and contrast-induced acute kidney injury (CI-AKI) by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Bivariable and multivariable logistic regression was utilized to analyze factors associated with AKI and the outcomes of these patients.

RESULTS

Twenty-two of the 227 (9.7%) participants sustained AKI. The majority of the study population was male and of Asian ethnicity. No statistically significant factors were associated with AKI. The in-hospital mortality rate was 9% for the AKI versus 2% for non-AKI groups. The AKI group had a longer hospital stay and required ICU care and organ support including hemodialysis.

CONCLUSIONS

Nearly 1-in-10 patients undergoing PCI are likely to develop AKI. The in-hospital mortality rate is x4.5 times higher for patients with AKI post-PCI compared to those without AKI. Further larger studies are recommended to determine factors associated with AKI in this population.

摘要

背景

冠状动脉疾病(CAD)是全球死亡率和发病率的主要原因。经皮冠状动脉介入治疗(PCI)是针对这些患者的一种微创救生干预措施;然而,急性肾损伤(AKI)是该手术的一种严重并发症,通常由放射造影剂诱发的肾病引起。

方法

在坦桑尼亚达累斯萨拉姆的阿迦汗医院(AKH,D)进行了一项回顾性横断面分析研究。共纳入了2014年8月至2020年12月期间接受经皮冠状动脉介入治疗的227名成年人。根据急性肾损伤网络(AKIN)使用的肌酐绝对值增加和百分比上升来定义AKI,并根据改善全球肾脏病预后组织(KDIGO)的标准定义造影剂诱发的急性肾损伤(CI-AKI)。采用双变量和多变量逻辑回归分析与AKI相关的因素以及这些患者的预后。

结果

227名参与者中有22名(9.7%)发生了AKI。研究人群中大多数为男性且是亚洲族裔。没有与AKI相关的统计学显著因素。AKI组的住院死亡率为9%,而非AKI组为2%。AKI组的住院时间更长,需要重症监护病房护理和包括血液透析在内的器官支持。

结论

近十分之一接受PCI的患者可能会发生AKI。PCI术后发生AKI的患者的住院死亡率比未发生AKI的患者高4.5倍。建议进行进一步的大型研究以确定该人群中与AKI相关的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e33/10103833/b93f3aea8030/cureus-0015-00000036219-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e33/10103833/b93f3aea8030/cureus-0015-00000036219-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e33/10103833/b93f3aea8030/cureus-0015-00000036219-i01.jpg

相似文献

1
Prevalence & Factors Associated With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention at a Tertiary Healthcare Facility in Tanzania.坦桑尼亚一家三级医疗机构中接受经皮冠状动脉介入治疗患者的急性肾损伤患病率及相关因素
Cureus. 2023 Mar 16;15(3):e36219. doi: 10.7759/cureus.36219. eCollection 2023 Mar.
2
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
3
Editor's Choice- What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?编辑精选- 急性心肌梗死后血清肌酐的小变化能告诉我们什么结局?
Eur Heart J Acute Cardiovasc Care. 2018 Dec;7(8):739-742. doi: 10.1177/2048872617728721. Epub 2017 Aug 29.
4
Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.在接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者中,桡动脉与股动脉入路与对比剂诱导的急性肾损伤的相关性。
Cardiovasc Revasc Med. 2016 Dec;17(8):546-551. doi: 10.1016/j.carrev.2016.07.008. Epub 2016 Jul 21.
5
Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.经皮冠状动脉介入治疗后急性肾损伤患者不良事件的纵向风险:来自国家心血管数据登记处的见解
Circ Cardiovasc Interv. 2017 Apr;10(4). doi: 10.1161/CIRCINTERVENTIONS.116.004439.
6
Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.慢性肾脏病患者经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤结局的预测因素
Am J Cardiol. 2014 Dec 15;114(12):1830-5. doi: 10.1016/j.amjcard.2014.09.022. Epub 2014 Sep 28.
7
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention.计算血清渗透压、急性肾损伤与经皮冠状动脉介入治疗后死亡率的关系。
Cardiorenal Med. 2019;9(3):160-167. doi: 10.1159/000494807. Epub 2019 Mar 7.
8
Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.急性冠状动脉综合征患者接受经皮冠状动脉介入治疗时输血与急性肾损伤风险
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003279.
9
Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.美国经皮冠状动脉介入治疗患者急性肾损伤发病率和增量成本的当代趋势。
Catheter Cardiovasc Interv. 2020 Nov;96(6):1184-1197. doi: 10.1002/ccd.28824. Epub 2020 Mar 4.
10
Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention.基于 KDIGO 标准的 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后发生的急性肾损伤。
J Nephrol. 2018 Jun;31(3):423-428. doi: 10.1007/s40620-017-0461-3. Epub 2017 Nov 28.

引用本文的文献

1
Percutaneous Coronary Intervention in Africa: A Systematic Review of Associated Outcomes.非洲的经皮冠状动脉介入治疗:相关结果的系统评价
Cureus. 2025 Jul 22;17(7):e88488. doi: 10.7759/cureus.88488. eCollection 2025 Jul.
2
Clinical characteristics and outcomes of patients undergoing percutaneous coronary intervention at Gesund Cardiac and Medical Center, Addis Ababa, Ethiopia, 2024.2024年埃塞俄比亚亚的斯亚贝巴格桑德心脏与医学中心接受经皮冠状动脉介入治疗患者的临床特征与结局
Am J Cardiovasc Dis. 2025 Feb 15;15(1):29-38. doi: 10.62347/RIAQ1956. eCollection 2025.

本文引用的文献

1
Racial Differences in AKI Incidence Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后急性肾损伤的发生率存在种族差异。
J Am Soc Nephrol. 2021 Mar;32(3):654-662. doi: 10.1681/ASN.2020040502. Epub 2020 Dec 18.
2
Impact of percutaneous coronary intervention on patients with impaired baseline renal function.经皮冠状动脉介入治疗对基线肾功能受损患者的影响。
Indian Heart J. 2020 Sep-Oct;72(5):356-361. doi: 10.1016/j.ihj.2020.07.006. Epub 2020 Jul 14.
3
Nomenclature for kidney function and disease-executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference.
肾脏功能与疾病命名法——来自改善全球肾脏病预后组织(KDIGO)共识会议的执行摘要及术语表
Eur Heart J. 2020 Dec 21;41(48):4592-4598. doi: 10.1093/eurheartj/ehaa650.
4
Acute kidney injury - A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.急性肾损伤 - ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后的常见且严重的并发症。
PLoS One. 2019 Dec 20;14(12):e0226625. doi: 10.1371/journal.pone.0226625. eCollection 2019.
5
Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.降低经皮冠状动脉介入治疗期间造影剂诱导的急性肾损伤发生率的手术策略
JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. doi: 10.1016/j.jcin.2019.04.055. Epub 2019 Sep 11.
6
Contrast-induced nephropathy following angiography and cardiac interventions.血管造影和心脏介入术后的对比剂肾病
Heart. 2016 Apr;102(8):638-48. doi: 10.1136/heartjnl-2014-306962. Epub 2016 Feb 8.
7
Contrast-Induced Acute Kidney Injury: An Update.对比剂诱导的急性肾损伤:最新进展
Cardiovasc Drugs Ther. 2016 Apr;30(2):215-28. doi: 10.1007/s10557-015-6635-0.
8
[Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes].[直接经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤:患病率、预测因素及预后]
Ter Arkh. 2015;87(6):50-55. doi: 10.17116/terarkh201587650-55.
9
Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.危重症老年患者急性肾损伤的危险因素:一项回顾性队列研究。
Am J Kidney Dis. 2015 Jun;65(6):860-9. doi: 10.1053/j.ajkd.2014.10.018. Epub 2014 Dec 6.
10
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.